付露，主要从事天然药物化学及其生物活性研究，整合超导核磁与高分辨质谱技术高效发掘中药来源的活性天然产物及天然新型骨架化合物。发表SCI论文11篇（其中第一作者4篇）、中文核心期刊论文1篇，并参与申报国家发明专利6项。

代表性学术成果

1. Fu, L., et al. (2024). NMR-Guided Isolation of Anti-inflammatory Carabranolides from the Fruits of Carpesium abrotanoides L. Journal of Natural Products, 87(7), 1786–1797.  

2. Fu, L., et al. (2024). Cevanine-type alkaloids from the bulbs of Fritillaria unibracteata var. wabuensis and their antifibrotic activities in vitro. Phytochemistry, 220, 114018.  

3. Fu, L., et al. (2022). New caffeoyl derivatives from Elephantopus scaber. Journal of Asian Natural Products Research, 24(8), 713–721.               

4. Fu, L., et al. (2021). New phenolic acids from the whole herb of Elephantopus scaber Linn. and their anti-inflammatory activity. Natural Product Research, 35(21), 3667–3674.

5. 付露，沙合尼西·赛力克江，洪吟秋，司金光，张涛，邹忠梅. 地胆草抗氧化活性成分分离鉴定. 中国实验方剂学杂志, 2019, (02): 156-162.

6. Pan, L., Fu, L., et al. (2021). New stilbenoligan and flavonoid from the roots of Caragana stenophylla Pojark. and their anti-inflammatory activity. Journal of Asian Natural Products Research, 23(7), 627–636.      

7. Meng, J., Liu, J., Fu, L.,et al. (2023). Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD. Viruses, 15(1), 160.   

8. Zhang, T., Zhang, Q., Fu, L., et al. (2019). New antiproliferative germacranolides from Carpesium divaricatum. RSC Advances, 9(20), 11493–11502.           

参与科研项目

2020.10-2023.01     澳门科学技术发展基金重点研发项目（800万澳门币），参与人

项目：融合人工智能和多组学技术开展川贝母等六种中药的多维度质量控制研究项目

2020.12-2021.04      澳门科学技术发展基金A类项目（40.4万澳门币），参与人

项目：抗新型冠狀病毒肺炎的特效中藥的研發

2021.03-2023.03      澳门科学技术发展基金与广东省科技厅联合科研资助项目（104.8万澳门币），参与人

项目：中药新药“玉蝴蝶祛斑膏”的质量标准提升及临床研究